Koppikar Utpal — SEC insider filings

SEC reporting owner CIK 1742696. 28 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-08-20 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Atara Biotherapeutics, Inc. (ATRA)Chief Financial Officer18—20 legs · 63,861 sh · $607,2854
C4 Therapeutics, Inc. (CCCC)Director61 leg · 5,667 sh · $31,735—5
Flexion Therapeutics Inc (FLXN)Director2——2
INSMED Inc (INSM)Director2——1

Insider filings — Koppikar Utpal

FiledFormIssuerReported transactionsSource
2026-10-203INSMED Inc (INSM)Holdings only — no transactions reportedEDGAR
2026-10-204INSMED Inc (INSM)Grant/award (A): 6,139EDGAR
2026-06-264C4 Therapeutics, Inc. (CCCC)Grant/award (A): 62,000 (derivative) @ $0EDGAR
2025-06-204C4 Therapeutics, Inc. (CCCC)Grant/award (A): 35,500 (derivative) @ $0EDGAR
2024-06-214C4 Therapeutics, Inc. (CCCC)Grant/award (A): 32,500 (derivative) @ $0EDGAR
2023-06-164C4 Therapeutics, Inc. (CCCC)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2023-03-064Atara Biotherapeutics, Inc. (ATRA)Sale (S): 6,871 @ $3.63EDGAR
2023-02-104C4 Therapeutics, Inc. (CCCC)Purchase (P): 5,667 @ $5.60EDGAR
2023-02-094Atara Biotherapeutics, Inc. (ATRA)Sale (S): 2,485 @ $5.46EDGAR
2022-11-184Atara Biotherapeutics, Inc. (ATRA)Sale (S): 5,172 @ $4.49 · Sale (S): 1,083 @ $4.49EDGAR
2022-08-184Atara Biotherapeutics, Inc. (ATRA)Sale (S): 5,940 @ $5.04EDGAR
2022-06-104Atara Biotherapeutics, Inc. (ATRA)Sale (S): 5,853 @ $5.63EDGAR
2022-05-194Atara Biotherapeutics, Inc. (ATRA)Sale (S): 4,616 @ $5.32 · Sale (S): 966 @ $5.32EDGAR
2022-03-174C4 Therapeutics, Inc. (CCCC)Grant/award (A): 41,200 (derivative) @ $0EDGAR
2022-03-034Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 61,235 @ $0 · Sale (S): 2,272 @ $9.86 · Sale (S): 1,491 @ $9.86 · Grant/award (A): 115,107 (derivative) @ $0EDGAR
2022-02-094Atara Biotherapeutics, Inc. (ATRA)Sale (S): 2,496 @ $14.46EDGAR
2021-11-194Flexion Therapeutics Inc (FLXN)Disposition to issuer (D): 32,000 (derivative)EDGAR
2021-11-184Atara Biotherapeutics, Inc. (ATRA)Sale (S): 3,655 @ $17.12EDGAR
2021-08-194Atara Biotherapeutics, Inc. (ATRA)Sale (S): 3,579 @ $12.53EDGAR
2021-07-124Flexion Therapeutics Inc (FLXN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2021-06-094Atara Biotherapeutics, Inc. (ATRA)Sale (S): 5,820 @ $14.06EDGAR
2021-05-204Atara Biotherapeutics, Inc. (ATRA)Sale (S): 3,616 @ $14.55EDGAR
2021-03-304Atara Biotherapeutics, Inc. (ATRA)Sale (S): 1,761 @ $14.58EDGAR
2021-03-044Atara Biotherapeutics, Inc. (ATRA)Sale (S): 1,461 @ $16.74EDGAR
2021-03-034Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 45,258 @ $0 · Grant/award (A): 68,314 (derivative) @ $0EDGAR
2021-02-094Atara Biotherapeutics, Inc. (ATRA)Sale (S): 1,759 @ $20.39EDGAR
2020-11-184Atara Biotherapeutics, Inc. (ATRA)Sale (S): 1,469 @ $19.77EDGAR
2020-08-204Atara Biotherapeutics, Inc. (ATRA)Sale (S): 1,496 @ $12.09EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742696 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs